Immunocompetent PDMS‐Free Organ‐on‐Chip Model of Cervical Cancer Integrating Patient‐Specific Cervical Fibroblasts and Neutrophils
Advanced Healthcare Materials · 2024-08 · 13 (21)
DOI: 10.1002/adhm.202302714 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.01.2024. Verfasst von Elena Kromidas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department for Microphysiological Systems, Institute of Biomedical Engineering, Faculty of Medicine, Eberhard Karls University Tübingen, 72074, Tübin…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Neutrophils, Fibroblasts, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Innovative Medicines Initiative 2, Bundesinstitut für Risikobewertung.
Abstract (Originalsprache)
Despite preventive measures and available treatments, cervical cancer still ranks as the fourth most prevalent cancer among women worldwide and remains the leading cause of cancer death in women in many developing countries. To gain further insights into pathogenesis and to develop novel (immuno)therapies, more sophisticated human models recreating patient heterogeneities and including aspects of the tumor microenvironment are urgently required. A novel polydimethylsiloxane‐free microfluidic platform, designed specifically for the generation and ccultivation of cervical cancerous tissue, is introduced. The microscale open‐top tissue chambers of the cervical cancer‐on‐chip (CCoC) enable facile generation and long‐term cultivation of SiHa spheroids in co‐culture with donor‐derived cervical fibroblasts. The resulting 3D tissue emulates physiological architecture and allows dissection of distinct effects of the stromal tissue on cancer viability and growth. Treatment with cisplatin at clinically‐relevant routes of administration and dosing highlights the platform's applicability for drug testing. Moreover, the model is amenable for integration and recruitment of donor‐derived neutrophils from the microvasculature‐like channel into the tissue, all while retaining their ability to produce neutrophil extracellular traps. In the future, the immunocompetent CCoC featuring donor‐specific primary cells and tumor spheroids has the potential to contribute to the development of new (immuno)therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Microphysiological Systems, Institute of Biomedical Engineering, Faculty of Medicine, Eberhard Karls University Tübingen, 72074, Tübingen, Germany.
- Department for Biomedicine and Materials Science, NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770, Reutlingen, Germany.
- Department for Women's Health, Faculty of Medicine, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.
- 3R Center Tübingen for In Vitro Models and Alternatives to Animal Testing, 72074, Tübingen, Germany.
ORCID-Profile: Peter Loskill
Förderung
- H2020 Innovative Medicines Initiative 2
- Bundesinstitut für Risikobewertung
Zitieren
APA
Kromidas, E., Geier, A., Weghofer, A., Liu, H. Y., Weiss, M., & Loskill, P. (2024). Immunocompetent PDMS‐Free Organ‐on‐Chip Model of Cervical Cancer Integrating Patient‐Specific Cervical Fibroblasts and Neutrophils. Advanced Healthcare Materials, 13(21). https://doi.org/10.1002/adhm.202302714
Vancouver
Kromidas E, Geier A, Weghofer A, Liu HY, Weiss M, Loskill P. Immunocompetent PDMS‐Free Organ‐on‐Chip Model of Cervical Cancer Integrating Patient‐Specific Cervical Fibroblasts and Neutrophils. Advanced Healthcare Materials. 2024;13(21). doi:10.1002/adhm.202302714
BibTeX
@article{Kromidas2024,
author = {Kromidas, Elena and Geier, Alicia and Weghofer, Adrian and Liu, Hui-Yu and Weiss, Martin and Loskill, Peter},
title = {Immunocompetent PDMS‐Free Organ‐on‐Chip Model of Cervical Cancer Integrating Patient‐Specific Cervical Fibroblasts and Neutrophils},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {21},
doi = {10.1002/adhm.202302714}
}
EUVIMED